The study is about testing a new medicine called VDPHL01 for male pattern baldness, also known as Androgenetic Alopecia (AGA). **AGA** is a genetic condition where hormones cause hair to fall out. The study will last about 13 months and involves 11 visits to check on participants' progress.

**Key Points to Consider:**

• The study lasts for 13 months with 11 visits, so participants need to be committed for over a year.
• Participants must agree to have their scalp photographed and a small tattoo mark for monitoring.
• Participants should not have used certain medications or treatments before joining the study, like hormone therapy or scalp procedures.

To join, you should be a male between 18 to 65 years old, with mild to moderate hair loss, and in good health. You must keep your hair at least 1/4 inch long and use the same hair care products throughout the study. Some medical conditions or recent treatments may prevent you from participating, so check if you meet all requirements.